Human PDCD1 (Programmed Cell Death Protein 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-04101P
SDS-PAGE analysis of Human PDCD1 (Programmed Cell Death Protein 1) - Recombinant Protein, CAT# BLT-04101P, showing >95% purity under 15% SDS-PAGE (Reduced)
Human PDCD1 (Programmed Cell Death Protein 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-04101P
Regular price
$59500
$595.00
Sale price$41500
$415.00Save $180
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $962.50 Original price: |
| 1 mg | $1,746.00 Original price: |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human PDCD1/PD-1/CD279 Protein |
| Product Overview | This recombinant human PDCD1/PD-1/CD279 protein includes amino acids 25-167+93aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id | Q15116 |
| Recommended Name | Programmed cell death protein 1 |
| Gene Name | PDCD1 |
| Synonyms | Programmed cell death protein 1;PDCD1;PD-1;hPD-1;CD279 |
| Species | Human |
| Predicted Molecular Mass | 16.8 kDa |
| Expression System | Mammalian Cell |
| Expression Range | 25-167+93aa |
| Tag | C-6His |
| Purity | >95% |
| Formulation | Lyophilized |
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Cell Biology, Cancer |
| Target Function | Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self. Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2. Following T-cell receptor (TCR) engagement, PDCD1 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation. Suppresses T-cell activation through the recruitment of PTPN11/SHP-2: following ligand-binding, PDCD1 is phosphorylated within the ITSM motif, leading to the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2 that mediates dephosphorylation of key TCR proximal signaling molecules, such as ZAP70, PRKCQ/PKCtheta and CD247/CD3zeta.; The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. The interaction with CD274/PDCD1L1 inhibits cytotoxic T lymphocytes (CTLs) effector function. The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy. |
| Subcellular Location | Cell membrane; Single-pass type I membrane protein. |
| Associated Diseases | Systemic lupus erythematosus 2 (SLEB2) |
